Skip to main content
SpringerLink
Log in
SpringerLink
Log in

Human Papillomavirus-Related Cancers

  • Chapter
  • First Online:
Infectious Agents Associated Cancers: Epidemiology and Molecular Biology

Part of the book series: Advances in Experimental Medicine and Biology ((AEMB,volume 1018))

Abstract

Human papillomavirus (HPV) infection is associated with several cancers such as cancer in the cervix, vagina, and vulva and oropharyngeal, anal, penile, and cutaneous carcinomas, which is regarded as a great public health concern. The association between HPV is the strongest with cervical cancer because almost all such malignancies contain viral DNA, notably HPV types 16 and 18. The present chapter summarizes recent progresses of the HPV-associated cancers regarding epidemiology, molecular biology, HPV testing, vaccination, and treatment of HPV-related cancers.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Humans IWGotEoCRt (2008) IARC monographs on the evaluation of carcinogenic risks to humans. Volume 97. 1,3-butadiene, ethylene oxide and vinyl halides (vinyl fluoride, vinyl chloride and vinyl bromide). IARC Monogr Eval Carcinog Risks Hum 97:3–471

    Google Scholar 

  2. Markowitz LE, Dunne EF, Saraiya M, Chesson HW, Curtis CR, Gee J, Bocchini JA Jr, Unger ER, Centers for Disease C, Prevention (2014) Human papillomavirus vaccination: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep: Morb Mortal Wkly Rep Recomm Rep 63:1–30

    Google Scholar 

  3. Bansal A, Singh MP, Rai B (2016) Human papillomavirus-associated cancers: a growing global problem. Int J Appl Basic Med Res 6:84–89

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. de Sanjose S, Diaz M, Castellsague X, Clifford G, Bruni L, Munoz N, Bosch FX (2007) Worldwide prevalence and genotype distribution of cervical human papillomavirus DNA in women with normal cytology: a meta-analysis. Lancet Infect Dis 7:453–459

    Article  PubMed  Google Scholar 

  5. Arbyn M, de Sanjose S, Saraiya M, Sideri M, Palefsky J, Lacey C, Gillison M, Bruni L, Ronco G, Wentzensen N, Brotherton J, Qiao YL, Denny L, Bornstein J, Abramowitz L, Giuliano A, Tommasino M, Monsonego J (2012) EUROGIN 2011 roadmap on prevention and treatment of HPV-related disease. Int J Cancer 131:1969–1982

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Valentino K, Poronsky CB (2016) Human papillomavirus infection and vaccination. J Pediatr Nurs 31:e155–e166

    Article  PubMed  Google Scholar 

  7. Mayeaux EJ Jr (2008) Reducing the economic burden of HPV-related diseases. J Am Osteopath Assoc 108:S2–S7

    PubMed  Google Scholar 

  8. Chelimo C, Wouldes TA, Cameron LD, Elwood JM (2013) Risk factors for and prevention of human papillomaviruses (HPV), genital warts and cervical cancer. J Infect 66:207–217

    Article  PubMed  Google Scholar 

  9. Bruni L, Diaz M, Castellsague X, Ferrer E, Bosch FX, de Sanjose S (2010) Cervical human papillomavirus prevalence in 5 continents: meta-analysis of 1 million women with normal cytological findings. J Infect Dis 202:1789–1799

    Article  PubMed  Google Scholar 

  10. Dunne EF, Unger ER, Sternberg M, McQuillan G, Swan DC, Patel SS, Markowitz LE (2007) Prevalence of HPV infection among females in the United States. JAMA 297:813–819

    Article  CAS  PubMed  Google Scholar 

  11. Matkins PP (2013) Sexually transmitted infections in adolescents. N C Med J 74:48–52

    PubMed  Google Scholar 

  12. Zheng ZM, Baker CC (2006) Papillomavirus genome structure, expression, and post-transcriptional regulation. Front Biosci: J Virtual Libr 11:2286–2302

    Article  CAS  Google Scholar 

  13. Doorbar J, Egawa N, Griffin H, Kranjec C, Murakami I (2015) Human papillomavirus molecular biology and disease association. Rev Med Virol 25(Suppl 1):2–23

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Zheng ZM (2010) Viral oncogenes, noncoding RNAs, and RNA splicing in human tumor viruses. Int J Biol Sci 6:730–755

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. Wiest T, Schwarz E, Enders C, Flechtenmacher C, Bosch FX (2002) Involvement of intact HPV16 E6/E7 gene expression in head and neck cancers with unaltered p53 status and perturbed pRb cell cycle control. Oncogene 21:1510–1517

    Article  CAS  PubMed  Google Scholar 

  16. Evander M, Frazer IH, Payne E, Qi YM, Hengst K, McMillan NA (1997) Identification of the alpha6 integrin as a candidate receptor for papillomaviruses. J Virol 71:2449–2456

    CAS  PubMed  PubMed Central  Google Scholar 

  17. Joyce JG, Tung JS, Przysiecki CT, Cook JC, Lehman ED, Sands JA, Jansen KU, Keller PM (1999) The L1 major capsid protein of human papillomavirus type 11 recombinant virus-like particles interacts with heparin and cell-surface glycosaminoglycans on human keratinocytes. J Biol Chem 274:5810–5822

    Article  CAS  PubMed  Google Scholar 

  18. Juckett G, Hartman-Adams H (2010) Human papillomavirus: clinical manifestations and prevention. Am Fam Physician 82:1209–1213

    PubMed  Google Scholar 

  19. Ikenberg H (2014) Laboratory diagnosis of human papillomavirus infection. Curr Probl Dermatol 45:166–174

    Article  PubMed  Google Scholar 

  20. Wiwanitkit V (2013) Cervista HPV HR test kit in cervical cancer screening. J Low Genit Tract Dis 17:99

    Article  PubMed  Google Scholar 

  21. Johnson LR, Starkey CR, Palmer J, Taylor J, Stout S, Holt S, Hendren R, Bock B, Waibel E, Tyree G, Miller GC (2008) A comparison of two methods to determine the presence of high-risk HPV cervical infections. Am J Clin Pathol 130:401–408

    Article  PubMed  Google Scholar 

  22. Rebolj M, Preisler S, Ejegod DM, Bonde J, Rygaard C, Lynge E (2013) Prevalence of Human Papillomavirus infection in unselected SurePath samples using the APTIMA HPV mRNA assay. J Mol Diagn: JMD 15:670–677

    Article  CAS  PubMed  Google Scholar 

  23. Wright TC, Stoler MH, Behrens CM, Sharma A, Zhang G, Wright TL (2015) Primary cervical cancer screening with human papillomavirus: end of study results from the ATHENA study using HPV as the first-line screening test. Gynecol Oncol 136:189–197

    Article  PubMed  Google Scholar 

  24. Forouzanfar MH, Foreman KJ, Delossantos AM, Lozano R, Lopez AD, Murray CJ, Naghavi M (2011) Breast and cervical cancer in 187 countries between 1980 and 2010: a systematic analysis. Lancet (London, England) 378:1461–1484

    Article  Google Scholar 

  25. Walboomers JM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, Shah KV, Snijders PJ, Peto J, Meijer CJ, Munoz N (1999) Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 189:12–19

    Article  CAS  PubMed  Google Scholar 

  26. Schiffman M, Kjaer SK (2003) Chapter 2: natural history of anogenital human papillomavirus infection and neoplasia. J Natl Cancer Inst Monogr 31:14–19

    Article  Google Scholar 

  27. de Sanjose S, Quint WG, Alemany L, Geraets DT, Klaustermeier JE, Lloveras B, Tous S, Felix A, Bravo LE, Shin HR, Vallejos CS, de Ruiz PA, Lima MA, Guimera N, Clavero O, Alejo M, Llombart-Bosch A, Cheng-Yang C, Tatti SA, Kasamatsu E, Iljazovic E, Odida M, Prado R, Seoud M, Grce M, Usubutun A, Jain A, Suarez GA, Lombardi LE, Banjo A, Menendez C, Domingo EJ, Velasco J, Nessa A, Chichareon SC, Qiao YL, Lerma E, Garland SM, Sasagawa T, Ferrera A, Hammouda D, Mariani L, Pelayo A, Steiner I, Oliva E, Meijer CJ, Al-Jassar WF, Cruz E, Wright TC, Puras A, Llave CL, Tzardi M, Agorastos T, Garcia-Barriola V, Clavel C, Ordi J, Andujar M, Castellsague X, Sanchez GI, Nowakowski AM, Bornstein J, Munoz N, Bosch FX (2010) Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study. Lancet Oncol 11:1048–1056

    Article  PubMed  Google Scholar 

  28. Giuliano AR, Harris R, Sedjo RL, Baldwin S, Roe D, Papenfuss MR, Abrahamsen M, Inserra P, Olvera S, Hatch K (2002) Incidence, prevalence, and clearance of type-specific human papillomavirus infections: The Young Women’s Health Study. J Infect Dis 186:462–469

    Article  PubMed  Google Scholar 

  29. Castle PE, Dockter J, Giachetti C, Garcia FA, McCormick MK, Mitchell AL, Holladay EB, Kolk DP (2007) A cross-sectional study of a prototype carcinogenic human papillomavirus E6/E7 messenger RNA assay for detection of cervical precancer and cancer. Clin Cancer Res: Off J Am Assoc Cancer Res 13:2599–2605

    Article  CAS  Google Scholar 

  30. Khan MJ, Castle PE, Lorincz AT, Wacholder S, Sherman M, Scott DR, Rush BB, Glass AG, Schiffman M (2005) The elevated 10-year risk of cervical precancer and cancer in women with human papillomavirus (HPV) type 16 or 18 and the possible utility of type-specific HPV testing in clinical practice. J Natl Cancer Inst 97:1072–1079

    Article  PubMed  Google Scholar 

  31. Dalstein V, Riethmuller D, Pretet JL, Le Bail CK, Sautiere JL, Carbillet JP, Kantelip B, Schaal JP, Mougin C (2003) Persistence and load of high-risk HPV are predictors for development of high-grade cervical lesions: a longitudinal French cohort study. Int J Cancer 106:396–403

    Article  CAS  PubMed  Google Scholar 

  32. Josefsson AM, Magnusson PK, Ylitalo N, Sorensen P, Qwarforth-Tubbin P, Andersen PK, Melbye M, Adami HO, Gyllensten UB (2000) Viral load of human papilloma virus 16 as a determinant for development of cervical carcinoma in situ: a nested case-control study. Lancet (London, England) 355:2189–2193

    Article  CAS  Google Scholar 

  33. Lillo FB, Lodini S, Ferrari D, Stayton C, Taccagni G, Galli L, Lazzarin A, Uberti-Foppa C (2005) Determination of human papillomavirus (HPV) load and type in high-grade cervical lesions surgically resected from HIV-infected women during follow-up of HPV infection. Clin Infect Dis : Off Publ Infect Dis Soc Am 40:451–457

    Article  Google Scholar 

  34. Ostor AG (1993) Natural history of cervical intraepithelial neoplasia: a critical review. Int J Gynecol Pathol: Off J Int Soc Gynecol Pathol 12:186–192

    Article  CAS  Google Scholar 

  35. Human papillomaviruses. IARC Monogr Eval Carcinog Risks Hum 90:1–636

    Google Scholar 

  36. Monnier-Benoit S, Dalstein V, Riethmuller D, Lalaoui N, Mougin C, Pretet JL (2006) Dynamics of HPV16 DNA load reflect the natural history of cervical HPV-associated lesions. J Clin Virol: Off Publ Pan Am Soc Clin Virol 35:270–277

    Article  CAS  Google Scholar 

  37. Peitsaro P, Johansson B, Syrjanen S (2002) Integrated human papillomavirus type 16 is frequently found in cervical cancer precursors as demonstrated by a novel quantitative real-time PCR technique. J Clin Microbiol 40:886–891

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  38. Saunier M, Monnier-Benoit S, Mauny F, Dalstein V, Briolat J, Riethmuller D, Kantelip B, Schwarz E, Mougin C, Pretet JL (2008) Analysis of human papillomavirus type 16 (HPV16) DNA load and physical state for identification of HPV16-infected women with high-grade lesions or cervical carcinoma. J Clin Microbiol 46:3678–3685

    Article  PubMed  PubMed Central  Google Scholar 

  39. Wang S, Wei H, Wang N, Zhang S, Zhang Y, Ruan Q, Jiang W, Xiao Q, Luan X, Qian X, Zhang L, Gao X, Sun X (2012) The prevalence and role of human papillomavirus genotypes in primary cervical screening in the northeast of China. BMC Cancer 12:160

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  40. Kahla S, Kochbati L, Maalej M, Oueslati R (2014) Situation of HPV16 E2 gene status during radiotherapy treatment of cervical carcinoma. Asian Pac J Cancer Prev 15:2869–2873

    Article  PubMed  Google Scholar 

  41. Gillison ML (2004) Human papillomavirus-associated head and neck cancer is a distinct epidemiologic, clinical, and molecular entity. Semin Oncol 31:744–754

    Article  PubMed  Google Scholar 

  42. Katki HA, Kinney WK, Fetterman B, Lorey T, Poitras NE, Cheung L, Demuth F, Schiffman M, Wacholder S, Castle PE (2011) Cervical cancer risk for women undergoing concurrent testing for human papillomavirus and cervical cytology: a population-based study in routine clinical practice. Lancet Oncol 12:663–672

    Article  PubMed  PubMed Central  Google Scholar 

  43. Leemans CR, Braakhuis BJ, Brakenhoff RH (2011) The molecular biology of head and neck cancer. Nat Rev Cancer 11:9–22

    Article  CAS  PubMed  Google Scholar 

  44. Hong AM, Dobbins TA, Lee CS, Jones D, Harnett GB, Armstrong BK, Clark JR, Milross CG, Kim J, O'Brien CJ, Rose BR (2010) Human papillomavirus predicts outcome in oropharyngeal cancer in patients treated primarily with surgery or radiation therapy. Br J Cancer 103:1510–1517

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  45. Sathish N, Wang X, Yuan Y (2014) Human Papillomavirus (HPV)-associated oral cancers and treatment strategies. J Dent Res 93:29s–36s

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  46. Mirghani H, Amen F, Blanchard P, Moreau F, Guigay J, Hartl DM, Lacau SGJ (2015) Treatment de-escalation in HPV-positive oropharyngeal carcinoma: ongoing trials, critical issues and perspectives. Int J Cancer 136:1494–1503

    Article  CAS  PubMed  Google Scholar 

  47. Abramowitz L, Jacquard AC, Jaroud F, Haesebaert J, Siproudhis L, Pradat P, Aynaud O, Leocmach Y, Soubeyrand B, Dachez R, Riethmuller D, Mougin C, Pretet JL, Denis F (2011) Human papillomavirus genotype distribution in anal cancer in France: the EDiTH V study. Int J Cancer 129:433–439

    Article  CAS  PubMed  Google Scholar 

  48. Stanley MA, Winder DM, Sterling JC, Goon PK (2012) HPV infection, anal intra-epithelial neoplasia (AIN) and anal cancer: current issues. BMC Cancer 12:398

    Article  PubMed  PubMed Central  Google Scholar 

  49. De Vuyst H, Clifford GM, Nascimento MC, Madeleine MM, Franceschi S (2009) Prevalence and type distribution of human papillomavirus in carcinoma and intraepithelial neoplasia of the vulva, vagina and anus: a meta-analysis. Int J Cancer 124:1626–1636

    Article  PubMed  Google Scholar 

  50. van Seters M, van Beurden M, de Craen AJ (2005) Is the assumed natural history of vulvar intraepithelial neoplasia III based on enough evidence? A systematic review of 3322 published patients. Gynecol Oncol 97:645–651

    Article  PubMed  Google Scholar 

  51. Orth G (2010) Genetics and susceptibility to human papillomaviruses: epidermodysplasia verruciformis, a disease model. Bull Acad Natl Med 194:923–940. discussion 941

    CAS  PubMed  Google Scholar 

  52. Lazarczyk M, Cassonnet P, Pons C, Jacob Y, Favre M (2009) The EVER proteins as a natural barrier against papillomaviruses: a new insight into the pathogenesis of human papillomavirus infections. Microbiol Mol Biol Rev: MMBR 73:348–370

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  53. Armstrong EP (2010) Prophylaxis of cervical cancer and related cervical disease: a review of the cost-effectiveness of vaccination against oncogenic HPV types. J Manage Care Pharm: JMCP 16:217–230

    Google Scholar 

  54. Quadrivalent vaccine against human papillomavirus to prevent high-grade cervical lesions. New Engl J Med 356:1915–1927

    Google Scholar 

  55. Paavonen J, Naud P, Salmeron J, Wheeler CM, Chow SN, Apter D, Kitchener H, Castellsague X, Teixeira JC, Skinner SR, Hedrick J, Jaisamrarn U, Limson G, Garland S, Szarewski A, Romanowski B, Aoki FY, Schwarz TF, Poppe WA, Bosch FX, Jenkins D, Hardt K, Zahaf T, Descamps D, Struyf F, Lehtinen M, Dubin G (2009) Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women. Lancet (London, England) 374:301–314

    Article  CAS  Google Scholar 

  56. Hariri S, Markowitz LE, Dunne EF, Unger ER (2013) Population impact of HPV vaccines: summary of early evidence. J Adolesc Health: Off Publ Soc Adolesc Med 53:679–682

    Article  Google Scholar 

  57. Ali H, Donovan B, Wand H, Read TR, Regan DG, Grulich AE, Fairley CK, Guy RJ (2013) Genital warts in young Australians five years into national human papillomavirus vaccination programme: national surveillance data. BMJ (Clin Res Ed) 346:f2032

    Google Scholar 

  58. Petrosky E, Bocchini JA Jr, Hariri S, Chesson H, Curtis CR, Saraiya M, Unger ER, Markowitz LE (2015) Use of 9-valent human papillomavirus (HPV) vaccine: updated HPV vaccination recommendations of the advisory committee on immunization practices. MMWR Morb Mortal Wkly Rep 64:300–304

    PubMed  Google Scholar 

  59. Nigam A, Saxena P, Acharya AS, Mishra A, Batra S (2014) HPV Vaccination in India: Critical Appraisal. ISRN Obstet Gynecol 2014:394595

    PubMed  PubMed Central  Google Scholar 

  60. Tahamtan A, Ghaemi A, Gorji A, Kalhor HR, Sajadian A, Tabarraei A, Moradi A, Atyabi F, Kelishadi M (2014) Antitumor effect of therapeutic HPV DNA vaccines with chitosan-based nanodelivery systems. J Biomed Sci 21:69

    Article  PubMed  PubMed Central  Google Scholar 

  61. McNamara M, Batur P, Walsh JM, Johnson KM (2016) HPV update: vaccination, screening, and associated disease. J Gen Intern Med 31:1360–1366

    Article  PubMed  Google Scholar 

  62. Grce M (2009) Primary and secondary prevention of cervical cancer. Expert Rev Mol Diagn 9:851–857

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Hospital and Institute of Obstetrics and Gynecology, Shanghai Medical College, Fudan University, Shanghai, 200032, People’s Republic of China

    Yanyun Li & Congjian Xu

Authors
  1. Yanyun Li
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Congjian Xu
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Congjian Xu .

Editor information

Editors and Affiliations

  1. Key Laboratory of Medical Molecular Virology (Ministries of Education and Health), School of Basic Medical Science Fudan University, Shanghai, China

    Qiliang Cai

  2. Key Laboratory of Medical Molecular Virology (Ministries of Education and Health), School of Basic Medical Science Fudan University, Shanghai, China

    Zhenghong Yuan

  3. State Key Laboratory of Virology, College of Life Science, Wuhan University, Wuhan, China

    Ke Lan

Rights and permissions

Reprints and permissions

Copyright information

© 2017 Springer Nature Singapore Pte Ltd.

About this chapter

Cite this chapter

Li, Y., Xu, C. (2017). Human Papillomavirus-Related Cancers. In: Cai, Q., Yuan, Z., Lan, K. (eds) Infectious Agents Associated Cancers: Epidemiology and Molecular Biology. Advances in Experimental Medicine and Biology, vol 1018. Springer, Singapore. https://doi.org/10.1007/978-981-10-5765-6_3

Download citation

Publish with us

Policies and ethics

Search

Navigation